CAR-T Cell Therapy for Solid Tumors
Background: Chimeric antigen receptor (CAR)-modified T cells have shown remarkable results for the treatment of selected hematological malignancies, but recapitulating these results in solid cancers has been a major challenge. In this review, we discuss lessons learned from recent clinica...
Saved in:
| Main Authors: | Liz T. Tony, Andrea Stabile, Marc P. Schauer, Michael Hudecek, Justus Weber |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Karger Publishers
2025-01-01
|
| Series: | Transfusion Medicine and Hemotherapy |
| Online Access: | https://karger.com/article/doi/10.1159/000542438 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CAR-armored-cell therapy in solid tumor treatment
by: Yan Liu, et al.
Published: (2024-11-01) -
Precision sniper for solid tumors: CAR-NK cell therapy
by: Sisi Li, et al.
Published: (2025-07-01) -
In-depth analysis of the safety of CAR-T cell therapy for solid tumors
by: Jiayi Dong, et al.
Published: (2025-02-01) -
CAR-NK cell therapy: promise and challenges in solid tumors
by: Sahar Balkhi, et al.
Published: (2025-04-01) -
Tailoring CAR surface density and dynamics to improve CAR-T cell therapy
by: Michael Hudecek, et al.
Published: (2025-04-01)